Literature DB >> 23899994

Pam3CSK(4) enhanced beta cell loss and diabetogenesis: the roles of IFN-gamma and IL-17.

Mariam Al Shamsi1, Allen Shahin, Yoichiro Iwakura, Miodrag L Lukic, Eric P K Mensah-Brown.   

Abstract

Toll like receptors are primary sensors of both innate and adaptive immune systems. They activate APCs and influence T-cell function in inflammatory autoimmune response. Studies have shown that TLR manipulation may lead to either tolerance or trigger autoimmunity. Using diabetogenic and subdiabetogenic multiple low doses of streptozotocin, we demonstrate here that Pam3 CYS-CK4 a TLR-2 agonist, enhances and promotes diabetes in C57BL/6 male mice following increased apoptosis of β islet cells. FACS analysis of isolated pancreatic lymph node cells revealed significant increased number of macrophages, dendritic cells, CD4(+) TNF-α(+), CD4(+) IFN-γ(+) and most significantly, CD4(+) IL-17(+) and reduced number of CD25(+)Fox p3(+) T cells after Pam3CSK4 treatment. Genetic deletion of IFN-γ prevents whereas deletion of IL-17 reduced severity of Pam3CSK4-induced enhancement of diabetes. TLR-2 agonist-enhanced diabetogenesis is also influenced by enhanced influx of antigen presenting cells and suppression of regulatory T cell activity.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Apoptosis; Autoimmunity; Proinflammatory cytokines; Subdiabetogenic dose

Mesh:

Substances:

Year:  2013        PMID: 23899994     DOI: 10.1016/j.clim.2013.06.001

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  4 in total

Review 1.  Epigenetic regulation of Toll-like receptors and its roles in type 1 diabetes.

Authors:  Zhiguo Xie; Gan Huang; Zhen Wang; Shuoming Luo; Peilin Zheng; Zhiguang Zhou
Journal:  J Mol Med (Berl)       Date:  2018-07-12       Impact factor: 4.599

Review 2.  Toll-Like Receptor Activation in Immunity vs. Tolerance in Autoimmune Diabetes.

Authors:  Elke Gülden; Li Wen
Journal:  Front Immunol       Date:  2014-03-24       Impact factor: 7.561

3.  Toll-like receptor 2 agonist exacerbates renal injury in diabetic mice.

Authors:  Fanglin Li; Ningyu Zhang; Zhiming Li; Lihua Deng; Jianjie Zhang; Yunfeng Zhou
Journal:  Exp Ther Med       Date:  2017-01-05       Impact factor: 2.447

4.  Expression of toll-like receptors 3, 7, and 9 in peripheral blood mononuclear cells from patients with systemic lupus erythematosus.

Authors:  Agnieszka Klonowska-Szymczyk; Anna Wolska; Tadeusz Robak; Barbara Cebula-Obrzut; Piotr Smolewski; Ewa Robak
Journal:  Mediators Inflamm       Date:  2014-02-25       Impact factor: 4.711

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.